ID: MRFR/Pharma/2408-CR | 260 Pages | Author: Rahul Gotadki | February 2021
1 Report Prologue
2 Introduction
2.1 Definition 13
2.2 Scope of Study 13
2.3 Research Objective 13
2.4 Assumptions & Limitations 14
2.4.1 Assumptions 14
2.4.2 Limitations 14
2.5 Market Structure 14
3 Research Methodology
3.1 Research Process 15
3.2 Primary Research 16
3.3 Secondary Research 16
3.4 Market Size Estimation 16
4 Market Dynamics
4.1 Drivers 18
4.1.1 Rising ageing population 18
4.1.2 Primal desire of humans to remain young 18
4.1.3 Influence of lifestyle industry and rising awareness 18
4.1.4 High levels of disposable incomes 18
4.2 Restraints 19
4.2.1 Scepticism and concerns of safety 19
4.2.2 Stringent regulations and definition ambiguity 19
4.3 Opportunities 19
4.3.1 Advancement in technologies and cellular understanding 19
4.3.2 Mergers, acquisitions and strategic alliances 20
4.4 Challenges 20
4.4.1 Steep competition 20
4.4.2 Ethical issues 20
4.4.3 Dubious and spurious products 20
5 Market Factor Analysis
5.1 Porter’s Five Force Analysis 21
5.1.1 Threat from a new entrant 22
5.1.2 Bargaining power of buyer 24
5.1.3 Bargaining power of supplier 24
5.1.4 Threat from substitute 24
5.1.5 Intensity of competitive rivalry 24
5.2 Supply Chain Analysis 25
5.2.1 Raw material 26
5.2.2 Supplier 26
5.2.3 Manufacturer 27
5.2.4 Distributer 27
5.2.5 Customer 28
5.2.6 Consumer 28
5.3 Technology Trends and Assessment 29
5.3.1 Caloric restriction mimetic drugs 29
5.3.2 Anti-oxidation strategy 29
5.3.3 Enzyme treatment 29
5.3.4 Nanotechnology 30
5.3.5 Genetics, cloning and strategies for engineered negligible senescence (SENS) 30
5.3.6 Hormonal therapy 31
5.4 Pipeline Analysis 31
5.4.1 Metformin in longevity study (MILES) 31
5.4.2 Vitamin D3 - Omega3 - Home Exercise (DO-HEALTH) 32
5.4.3 OpRegen 32
5.4.4 Study of Acarbose in Longevity (SAIL) 33
5.5 New Revenue Pockets Analysis 33
5.5.1 Introduction 33
5.5.2 New revenue segments 33
5.5.2.1 Stem cells and cell banking for future autologous cell therapies 33
5.5.2.2 Diseases related to ageing 34
5.5.2.3 Cryogenic preservation 34
5.5.2.4 Biomarkers 34
5.5.3 New revenue markets 34
6 Anti-Ageing Drugs Market, By Drug Class
6.1 Introduction 35
6.2 Serums and Supplements 37
6.3 Antioxidants and Enzymes 38
6.4 Stem Cells 39
6.5 Drugs 40
7 Anti-Ageing Market, By Application
7.1 Introduction 41
7.2 Skin and Hair 42
7.3 Skeletal and Muscles 43
7.4 Age related disorders 44
7.5 Others 45
8 Global Anti-Ageing Market, By Region
8.1 Introduction 46
8.2 North America 48
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.2.1 US 49
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.2.2 Canada 50
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.3 Europe 52
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.3.1 Germany 53
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.3.2 France 54
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.3.3 UK 55
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.3.4 Italy 56
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.3.5 Spain 57
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.3.6 Rest of Europe 58
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.4 Asia Pacific 60
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.4.1 Japan 61
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.4.2 China 62
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.4.3 India 63
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.4.4 Australia 64
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.4.5 Republic of Korea 65
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.4.6 Rest of Asia Pacific 66
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.5 Middle East and Africa 68
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.5.1 Middle east 69
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
8.5.2 Africa 70
Anti-Ageing Drugs Market, By Drug Class
Anti-Ageing Market, By Application
9 Company Profiles
9.1 Nu Skin 72
9.1.1 Company Overview 72
9.1.2 Product Overview 72
9.1.3 Financial Overview 73
9.1.4 Key Developments 74
9.1.5 SWOT 76
9.2 BIOTIME, INC. 77
9.2.1 Company Overview 77
9.2.2 Product Overview 77
9.2.3 Financial Overview 77
9.2.4 Key Developments 78
9.2.5 SWOT 79
9.3 Elysium Health Inc. 80
9.3.1 Company Overview 80
9.3.2 Product Overview 80
9.3.3 Financial Overview 80
9.3.4 Key Developments 80
9.3.5 SWOT 81
9.4 La Roche-Posay 82
9.4.1 Company Overview 82
9.4.2 Product Overview 82
9.4.3 Financial Overview 82
9.4.4 Key Developments 82
9.5 L'Oréal 83
9.5.1 Company Overview 83
9.5.2 Product Overview 83
9.5.3 Financial Overview 83
9.5.4 Key Developments 85
9.5.5 SWOT 86
9.6 DermaFix 87
9.6.1 Company Overview 87
9.6.2 Product Overview 87
9.6.3 Financial Overview 87
9.6.4 Key Developments 87
9.6.5 SWOT 88
10 MRFR Conclusion
10.1 Key Findings 89
10.1.1 From CEO’s View Point 89
10.1.2 Unmet Needs 89
10.2 Key Companies to Watch 89
11 List of Tables
TABLE 1 PIPELINE ANALYSIS 31
TABLE 2 GLOBAL ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 35
TABLE 3 GLOBAL ANTI-AGEING DRUGS MARKET FOR SERUMS AND SUPPLEMENTS BY REGION, 2020-2027 (USD MILLION) 37
TABLE 4 GLOBAL ANTI-AGEING DRUGS MARKET FOR ANTIOXIDANTS AND ENZYMES BY REGION, 2020-2027 (USD MILLION) 38
TABLE 5 GLOBAL ANTI-AGEING DRUGS MARKET FOR STEM CELLS BY REGION, 2020-2027 (USD MILLION) 39
TABLE 6 GLOBAL ANTI-AGEING DRUGS MARKET FOR DRUGS BY REGION, 2020-2027 (USD MILLION) 40
TABLE 7 GLOBAL ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 41
TABLE 8 GLOBAL ANTI-AGEING DRUGS MARKET FOR SKIN AND HAIR BY REGION, 2020-2027 (USD MILLION) 42
TABLE 9 GLOBAL ANTI-AGEING DRUGS MARKET FOR SKELETAL AND MUSCLES BY REGION, 2020-2027 (USD MILLION) 43
TABLE 10 GLOBAL ANTI-AGEING DRUGS MARKET FOR AGE RELATED DISORDERS BY REGION, 2020-2027 (USD MILLION) 44
TABLE 11 GLOBAL ANTI-AGEING DRUGS MARKET FOR OTHERS BY REGION, 2020-2027 (USD MILLION) 45
TABLE 12 GLOBAL ANTI-AGEING MARKET BY REGION, 2020-2027 (USD MILLION) 46
TABLE 13 NORTH AMERICA ANTI-AGEING MARKET BY COUNTRY, 2020-2027 (USD MILLION) 48
TABLE 14 NORTH AMERICA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 48
TABLE 15 NORTH AMERICA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 49
TABLE 16 US ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 49
TABLE 17 US ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 50
TABLE 18 CANADA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 50
TABLE 19 CANADA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 51
TABLE 20 EUROPE ANTI-AGEING MARKET BY COUNTRY, 2020-2027 (USD MILLION) 52
TABLE 21 EUROPE ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 52
TABLE 22 EUROPE ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 53
TABLE 23 GERMANY ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 53
TABLE 24 GERMANY ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 54
TABLE 25 FRANCE ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 54
TABLE 26 FRANCE ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 55
TABLE 27 UK ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 55
TABLE 28 U.K. ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 56
TABLE 29 ITALY ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 56
TABLE 30 ITALY ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 57
TABLE 31 SPAIN ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 57
TABLE 32 SPAIN ANTI-AGEING MARKET BY APPLICATIONS 58
TABLE 33 REST OF EUROPE ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 58
TABLE 34 REST OF EUROPE ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 59
TABLE 35 ASIA PACIFIC ANTI-AGEING MARKET BY COUNTRY, 2020-2027 (USD MILLION) 60
TABLE 36 ASIA PACIFIC ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 60
TABLE 37 ASIA PACIFIC ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 61
TABLE 38 JAPAN ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 61
TABLE 39 JAPAN ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 62
TABLE 40 CHINA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 62
TABLE 41 CHINA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 63
TABLE 42 INDIA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 63
TABLE 43 INDIA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 64
TABLE 44 AUSTRALIA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 64
TABLE 45 AUSTRALIA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 65
TABLE 46 REPUBLIC OF KOREA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 65
TABLE 47 REPUBLIC OF KOREA ANTI-AGEING MARKET BY APPLICATION, 2020-2027 (USD MILLION) 66
TABLE 48 REST OF ASIA PACIFIC ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 66
TABLE 49 REST OF ASIA PACIFIC ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 67
TABLE 50 MIDDLE EAST AND AFRICA ANTI-AGEING MARKET BY COUNTRY, 2020-2027 (USD MILLION) 68
TABLE 51 MIDDLE EAST AND AFRICA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 68
TABLE 52 MIDDLE EAST AND AFRICA ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 69
TABLE 53 MIDDLE EAST ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 69
TABLE 54 MIDDLE EAST ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 70
TABLE 55 AFRICA ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 70
TABLE 56 AFRICA ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 71
TABLE 57 NU SKIN: KEY DEVELOPMENTS 74
TABLE 58 BIOTIME, INC.: KEY DEVELOPMENTS 78
TABLE 59 ELYSIUM HEALTH INC.:KEY DEVELOPMENTS 80
TABLE 60 L'ORÉAL :KEY DEVELOPMENTS 85
12 List of Figures
FIGURE 1 GLOBAL ANTI-AGEING DRUGS MARKET BY DRUG CLASS MARKET SHARE, 2020 (%) 11
FIGURE 2 GLOBAL ANTI-AGEING DRUGS MARKET BY APPLICATIONS MARKET SHARE, 2020 (%) 11
FIGURE 3 GLOBAL ANTI-AGEING DRUGS MARKET BY REGION MARKET SHARE, 2020 (%) 12
FIGURE 4 GLOBAL ANTI-AGING DRUGS MARKET: MARKET STRUCTURE 14
FIGURE 5 RESEARCH PROCESS OF MRFR 15
FIGURE 6 GLOBAL ANTI-AGING DRUGS MARKET: PORTER FIVE FORCES ANALYSIS 22
FIGURE 7 GLOBAL ANTI-AGEING MARKET BY DRUG CLASS, 2020-2027 (USD MILLION) 36
FIGURE 8 GLOBAL ANTI-AGEING MARKET BY APPLICATIONS, 2020-2027 (USD MILLION) 42
FIGURE 9 GLOBAL ANTI-AGEING MARKET BY REGION, 2020 (%) 47
FIGURE 10 NU SKIN: RECENT FINANCIALS 73
FIGURE 11 NU SKIN: GEOGRAPHICAL MIX, 2020 (%) 73
FIGURE 12 NU SKIN: BUSINESS MIX, 2020 (%) 74
FIGURE 13 NU SKIN: SWOT ANALYSIS 76
FIGURE 14 BIOTIME INC.: RECENT FINANCIALS 77
FIGURE 15 BIOTIME, INC.: SWOT ANALYSIS 79
FIGURE 16 ELYSIUM HEALTH INC.: SWOT ANALYSIS 81
FIGURE 17 L'ORÉAL: RECENT FINANCIALS 83
FIGURE 18 L'ORÉAL: GEOGRAPHIC MIX, 2020 (%) 84
FIGURE 19 L'ORÉAL: SEGMENT MIX, 2020 (%) 84
FIGURE 20 L'ORÉAL: SWOT ANALYSIS 86
FIGURE 21 DERMAFIX: SWOT ANALYSIS 88
Market Segmentation for Anti-Ageing Drugs Market
Anti-Ageing Drugs Drug Class Outlook (USD Billion, 2019-2030)
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Anti-Ageing Drugs Application Outlook (USD Billion, 2019-2030)
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
OthersÂ
Anti-Ageing Drugs Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
North America Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
North America Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
US Outlook (USD Billion, 2019-2030)
US Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
US Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Canada Outlook (USD Billion, 2019-2030)
Canada Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Canada Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Europe Outlook (USD Billion, 2019-2030)
Europe Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Europe Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Germany Outlook (USD Billion, 2019-2030)
Germany Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Germany Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
France Outlook (USD Billion, 2019-2030)
France Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
France Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
UK Outlook (USD Billion, 2019-2030)
UK Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
UK Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Italy Outlook (USD Billion, 2019-2030)
Italy Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Italy Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Other
Spain Outlook (USD Billion, 2019-2030)
Spain Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Spain Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Rest of Europe Outlook (USD Billion, 2019-2030)
Rest of Europe Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Rest of Europe Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Asia-Pacific Outlook (USD Billion, 2019-2030)
Asia-Pacific Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Asia-Pacific Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
China Outlook (USD Billion, 2019-2030)
China Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
China Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Japan Outlook (USD Billion, 2019-2030)
Japan Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Japan Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
India Outlook (USD Billion, 2019-2030)
India Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
India Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Australia Outlook (USD Billion, 2019-2030)
Australia Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Australia Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
South Korea Outlook (USD Billion, 2019-2030)
South Korea Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
South Korea Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Rest of Asia-Pacific Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Rest of the World Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Middle East Outlook (USD Billion, 2019-2030)
Middle East Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Middle East Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Africa Outlook (USD Billion, 2019-2030)
Africa Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Africa Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Latin America Outlook (USD Billion, 2019-2030)
Latin America Anti-Ageing Drugs by Drug Class
Serums And Supplements
Antioxidants And Enzymes
Stem Cells
Drugs
Latin America Anti-Ageing Drugs by Application
Skin And HairÂ
Skeletal And Muscles
Age Related Disorders
Others
Research Methodology on Anti Ageing Drugs Market
Research Approach
The research approach for this research report is divided into five distinct sections, namely: 1) Literature review, 2) Development and Evaluation of the Research Model,3) Data Collection and Analysis, 4) Results and Findings and 5) Conclusion.
1. Literature review
For this research, a literature review is done to gain a holistic understanding of the Anti-ageing Drugs market. The extent of the literature reviewed is mainly focused on current market trends, emerging technologies, drivers and restraints, market segments, competitive landscape, etc. Primary sources include published reports, books and other documents and secondary sources include government reports, analyst reports newspaper and magazine articles, databases, online materials and internet resources. The findings of the literature review were used to gain an insight into the competitive dynamics of the Anti-ageing Drugs market, key opportunities and sales outlook.
2. Development and Evaluation of the Research Model
The research model for this research report is developed using PESTEL and Porter’s Five Force Analysis framework. Through PESTEL analysis, the key macro-environmental factors that affect the Anti-ageing Drugs market were identified and analysed. Alongside, Porter’s Five Forces analysis was used to determine the competitive intensity within the market, further allowing the research team to gain insight into the bargaining powers of suppliers, buyers, and the extent of competition within the market.
3. Data Collection and Analysis
The data used in this research report is collected from a variety of sources including primary and secondary sources. Primary sources include interviews with industry experts and industry stakeholders. The interviews were conducted to gain an in-depth understanding of the market dynamics, current trends, challenges, etc. Secondary sources include industry journals, newspapers, and other published documents available in the public domain. The research team also conducted an in-depth analysis of the published reports, databases such as Bloomberg, Factiva, and EDGAR.
The data collected from these different sources were analysed using both qualitative and quantitative research techniques. Statistical tools such as SPSS and EXCEL were used for analysing the data to identify trends and relationships.
4. Results and Findings
The results and findings of the research report were based on the analysis carried out on the collected data. Based on the analysis, the report provided a detailed overview of the Anti-ageing Drugs market, with an in-depth analysis of the market drivers, challenges, and opportunities. It also provided an analysis of the various market segments and a detailed view of the competitive landscape.
5. Conclusion
Based on the results and findings, the research report provided a detailed overview of the Anti-ageing Drugs market and a detailed analysis of the key market players. Further, it provided an insight into the challenges and opportunities in the Anti-ageing Drugs market. The research report concluded with a comprehensive evaluation of the market trends, segment outlook, and an outlook for the future of the Anti-ageing Drugs market.